Submit Deal

COHERUS BIOSCIENCES

Summary

Coherus BioSciences is a United States based biotherapeutics company engaged in developing and commercializing biosimilar therapeutics.

Deals Overview

Total Deals5

Valued Deals5

Total Value£ 693 M

Avg. Deal Size£ 139 M

Market Context

Senior Management

Denny Lanfear
Chairman and CEO
McDavid Stilwell
EVP, Financial Strategy and IR
Jami Taylor
Head of Investor Relations

Sort

jones day

HQ - Cleveland

legal advisors (1)

1 Shared Deal

1 Opposite

£ 36 M

Total Value

wedbush securities

financial advisors (1)

1 Shared Deal

1 Opposite

£ 51 M

Total Value

goodwin procter

HQ - Boston

legal advisors (1)

1 Shared Deal

1 Opposite

£ 51 M

Total Value

latham & watkins

HQ - New York, United States

legal advisors (4)

4 Shared Deals

4 For

£ 657 M

Total Value

truist securities

HQ - Atlanta

financial advisors (1)

1 Shared Deal

1 For

£ 51 M

Total Value

arnold & porter kaye scholer

HQ - Washington, D.C.

legal advisors (1)

1 Shared Deal

1 For

£ 51 M

Total Value

white & case

HQ - New York

legal advisors (1)

1 Shared Deal

1 For

£ 51 M

Total Value

jp morgan

HQ - New York

financial advisors (2)

2 Shared Deals

2 For

£ 574 M

Total Value

houlihan lokey

HQ - Los Angeles

financial advisors (1)

1 Shared Deal

1 For

£ 134 M

Total Value

rothschild & co

HQ - Paris

financial advisors (1)

1 Shared Deal

1 Opposite

£ 134 M

Total Value

argot partners

pr advisors (1)

1 Shared Deal

1 For

£ 440 M

Total Value

smith anderson

HQ - Raleigh

legal advisors (1)

1 Shared Deal

1 Opposite

£ 440 M

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy